These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 34431044)
1. MiR-1273 g-3p Promotes Malignant Progression and has Prognostic Implications in Prostate Cancer. Chang Y; Deng Q; Guan Z; Cheng Y; Sun Y Mol Biotechnol; 2022 Jan; 64(1):17-24. PubMed ID: 34431044 [TBL] [Abstract][Full Text] [Related]
2. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2. Pan MZ; Song YL; Gao F Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8795-8805. PubMed ID: 31696466 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of microRNA-423-3p indicates poor prognosis and promotes cell proliferation, migration, and invasion of lung cancer. Wang R; Li G; Zhuang G; Sun S; Song Z Diagn Pathol; 2019 Jun; 14(1):53. PubMed ID: 31164163 [TBL] [Abstract][Full Text] [Related]
4. PCGEM1 promotes proliferation, migration and invasion in prostate cancer by sponging miR-506 to upregulate TRIAP1. Liu H; He X; Li T; Qu Y; Xu L; Hou Y; Fu Y; Wang H BMC Urol; 2022 Feb; 22(1):14. PubMed ID: 35109849 [TBL] [Abstract][Full Text] [Related]
5. miR-1231 Is Downregulated in Prostate Cancer with Prognostic and Functional Implications. Wang Y; Zhang Q; Guo B; Feng J; Zhao D Oncol Res Treat; 2020; 43(3):78-86. PubMed ID: 31822000 [TBL] [Abstract][Full Text] [Related]
6. Transcription factor p53-mediated activation of miR-519d-3p and downregulation of E2F1 attenuates prostate cancer growth and metastasis. Zhang D; Yang XJ; Luo QD; Xue L; Chong T Cancer Gene Ther; 2022 Jul; 29(7):1001-1011. PubMed ID: 34799723 [TBL] [Abstract][Full Text] [Related]
8. MiR-5195-3p functions as a tumor suppressor in prostate cancer via targeting CCNL1. Zeng X; Hu Z; Shen Y; Wei X; Gan J; Liu Z Cell Mol Biol Lett; 2022 Mar; 27(1):25. PubMed ID: 35260070 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer. Ma T; Chen H; Wang P; Yang N; Bao J Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162 [No Abstract] [Full Text] [Related]
10. miR-654-3p predicts the prognosis of hepatocellular carcinoma and inhibits the proliferation, migration, and invasion of cancer cells. Yang J; Zhang Z; Chen S; Dou W; Xie R; Gao J Cancer Biomark; 2020; 28(1):73-79. PubMed ID: 32176631 [TBL] [Abstract][Full Text] [Related]
11. MiR-455-3p downregulation facilitates cell proliferation and invasion and predicts poor prognosis of osteosarcoma. Yi X; Wang Y; Xu S J Orthop Surg Res; 2020 Oct; 15(1):454. PubMed ID: 33008443 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of microRNA miR-652-3p is a prognostic risk factor for hepatocellular carcinoma and regulates cell proliferation, migration, and invasion. Chi X; Jiang Y; Chen Y; Lv L; Chen J; Yang F; Zhang X; Pan F; Cai Q Bioengineered; 2021 Dec; 12(1):7519-7528. PubMed ID: 34608826 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of MicroRNA-937 Predicts a Poor Prognosis and Promotes Hepatocellular Carcinoma Cell Proliferation, Migration, and Invasion. Chen Z; Zhang Y Mol Biotechnol; 2022 Jan; 64(1):33-41. PubMed ID: 34519997 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1. Wang M; Yu W; Gao J; Ma W; Frentsch M; Thiel A; Liu M; Rahman N; Qin Z; Li X J Cell Physiol; 2020 Feb; 235(2):1588-1600. PubMed ID: 31309555 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-383-5p acts as a potential prognostic biomarker and an inhibitor of tumor cell proliferation, migration, and invasion in breast cancer. Zhang J; Kong X; Shi Q; Zhao B Cancer Biomark; 2020; 27(4):423-432. PubMed ID: 31903982 [TBL] [Abstract][Full Text] [Related]
16. TGF-β1-regulated miR-3691-3p targets Hu YM; Lou XL; Liu BZ; Sun L; Wan S; Wu L; Zhao X; Zhou Q; Sun MM; Tao K; Zhang YS; Wang SL Asian J Androl; 2021; 23(2):188-196. PubMed ID: 33159025 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancer. Ling XH; Han ZD; Xia D; He HC; Jiang FN; Lin ZY; Fu X; Deng YH; Dai QS; Cai C; Chen JH; Liang YX; Zhong WD; Wu CL Mol Biol Rep; 2014 May; 41(5):2779-88. PubMed ID: 24452717 [TBL] [Abstract][Full Text] [Related]
18. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F. Yang H; Wei YN; Zhou J; Hao TT; Liu XL Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965 [TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer. Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409 [TBL] [Abstract][Full Text] [Related]
20. LncRNA CCDC144NL-AS1 Serves as a Prognosis Biomarker for Non-small Cell Lung Cancer and Promotes Cellular Function by Targeting miR-490-3p. Zhang L; Chi B; Chai J; Qin L; Zhang G; Hua P; Jin C Mol Biotechnol; 2021 Oct; 63(10):933-940. PubMed ID: 34115289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]